Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Prevalence of G-6-PD deficiency in Burkina Faso according to several authors

From: Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review

Characteristics G-6-PD deficiency
Sample Method Origin Author Year Malaria Male Female
498 PCR/RFLP Oubritenga Modiano et al. 2001 asymptomatic a16.7%
222 Enzymatic test Nouna Meissner et al. 2005 symptomatic 15,1% 7,0%
750 Enzymatic test Nouna Coulibaly et al. 2005 asymptomatic 16.9% 7.6%
342 Enzymatic test Kadiogo Simporé et al. 2007 No 20.5% 12.3%
357 PCR/RFLP Ouagadougou Carter et al. 2011 symptomatic 15.4% 3.3%
232 Enzymatic test Banfora Badoun et al. 2014 symptomatic 4.74% 2.15%
200 Real Time PCR Koubri Ouattara et al. 2014 asymptomatic 14.3% 6.0%
182 Classic PCR Ouagadougou Ouattara et al. 2016 symptomatic 15.2% 4.4%
  1. aNo information about prevalence according to gender
Back to article page